Steward Partners Investment Advisory’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-968
| Closed | -$5.65K | – | 3460 |
|
2022
Q4 | $5.65K | Sell |
968
-1,000
| -51% | -$5.84K | ﹤0.01% | 2734 |
|
2022
Q3 | $13K | Hold |
1,968
| – | – | ﹤0.01% | 2431 |
|
2022
Q2 | $8K | Hold |
1,968
| – | – | ﹤0.01% | 2614 |
|
2022
Q1 | $7K | Sell |
1,968
-4,009
| -67% | -$14.3K | ﹤0.01% | 2803 |
|
2021
Q4 | $19K | Sell |
5,977
-7,525
| -56% | -$23.9K | ﹤0.01% | 2356 |
|
2021
Q3 | $44K | Sell |
13,502
-2,517
| -16% | -$8.2K | ﹤0.01% | 1973 |
|
2021
Q2 | $68K | Sell |
16,019
-404,935
| -96% | -$1.72M | ﹤0.01% | 2772 |
|
2021
Q1 | $2.1M | Buy |
420,954
+345,943
| +461% | +$1.73M | 0.04% | 419 |
|
2020
Q4 | $948K | Sell |
75,011
-2,205
| -3% | -$27.9K | 0.02% | 578 |
|
2020
Q3 | $758K | Sell |
77,216
-1,217
| -2% | -$11.9K | 0.02% | 563 |
|
2020
Q2 | $780K | Buy |
78,433
+6,165
| +9% | +$61.3K | 0.02% | 519 |
|
2020
Q1 | $638K | Sell |
72,268
-5,115
| -7% | -$45.2K | 0.02% | 504 |
|
2019
Q4 | $713K | Buy |
77,383
+7,936
| +11% | +$73.1K | 0.02% | 536 |
|
2019
Q3 | $408K | Buy |
69,447
+3,305
| +5% | +$19.4K | 0.01% | 644 |
|
2019
Q2 | $793K | Buy |
66,142
+5,107
| +8% | +$61.2K | 0.03% | 438 |
|
2019
Q1 | $736K | Buy |
61,035
+2,350
| +4% | +$28.3K | 0.03% | 427 |
|
2018
Q4 | $736K | Buy |
58,685
+10,725
| +22% | +$135K | 0.04% | 400 |
|
2018
Q3 | $712K | Buy |
47,960
+4,700
| +11% | +$69.8K | 0.03% | 427 |
|
2018
Q2 | $728K | Buy |
43,260
+13,260
| +44% | +$223K | 0.04% | 373 |
|
2018
Q1 | $687K | Buy |
30,000
+14,350
| +92% | +$329K | 0.05% | 346 |
|
2017
Q4 | $404K | Buy |
15,650
+10,650
| +213% | +$275K | 0.03% | 406 |
|
2017
Q3 | $73K | Buy |
5,000
+2,550
| +104% | +$37.2K | 0.01% | 604 |
|
2017
Q2 | $34K | Hold |
2,450
| – | – | ﹤0.01% | 729 |
|
2017
Q1 | $41K | Buy |
+2,450
| New | +$41K | 0.01% | 601 |
|